Your browser doesn't support javascript.
loading
14q22.3 duplication including OTX2 in a girl with medulloblastoma: A case report with literature review.
Blake, Claire; Widmeyer, Kimmie; DAquila, Kristen; Mochizuki, Aaron; Smolarek, Teresa A; Pillay-Smiley, Natasha; Kim, Sun Young.
Affiliation
  • Blake C; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Widmeyer K; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • DAquila K; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Mochizuki A; Cancer and Blood Disease Institute, The Cure Starts Now Foundation Brain Tumor Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Smolarek TA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Pillay-Smiley N; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Kim SY; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Am J Med Genet A ; 194(7): e63604, 2024 07.
Article de En | MEDLINE | ID: mdl-38511879
ABSTRACT
Orthodenticle homeobox 2 (OTX2) is a known oncogenic driver of medulloblastoma. Germline duplication of 14q22.3 including OTX2 is a rare condition reported in patients with combined pituitary hormone deficiency, oculo-auriculo-vertebral spectrum, and hemifacial microsomia. There has been one previously published case of a patient carrying a 14q22.3 duplication that included OTX2 with hemifacial microsomia who also developed medulloblastoma. Here, we present a case of a 6-year-old girl with a history of delayed development who was diagnosed with medulloblastoma. Genetic evaluations revealed that she inherited a germline duplication of 14q22.3, which included OTX2. This genetic alteration was passed down from her mother, who also had a history of delayed development. Results from other genetic testing, including exome sequencing, fragile X syndrome, and mtDNA testing, were negative/normal. This is the second report of a 14q22.3 duplication that included OTX2 in a patient with medulloblastoma. Further studies are necessary to establish a clear association.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteurs de transcription Otx / Médulloblastome Limites: Child / Female / Humans Langue: En Journal: Am J Med Genet A Sujet du journal: GENETICA MEDICA Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteurs de transcription Otx / Médulloblastome Limites: Child / Female / Humans Langue: En Journal: Am J Med Genet A Sujet du journal: GENETICA MEDICA Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique